Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 299.81$. Average daily volumn in 3 months 3.1M. Market cap 308.07B



Stock symbol : LLY. Exchange : NYSE. Currency : USD
Lastest price : 324.23$. Total volume : 2.69M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Eli Lilly and Company (LLY)
Last Price
324.23$
Change
1.23
Volume
2.69M

Previous Close323.00
Open322.13
Day Range320.01-327.05
Bid323.00 x 900
Ask326.95 x 800
Volume2.69M
Average Volume3.1M
Market Cap308.07B
Beta0.40
52 Week Range220.20-330.85
Trailing P/E48.18
Foward P/E35.67
Dividend (Yield %)1.21%
Ex-Dividend Date2022-08-12



Financial Details


According to Eli Lilly and Company's financial reports the company's revenue in 2021 were 28.32B an increase( +16.67%) over the years 2020 revenue that were of 24.54B. In 2021 the company's total earnings were 5.58B while total earnings in 2020 were 6.19B(-16.67%).


Loading ...



Organization

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

eli-lilly-and-company-logo

Market Cap:
308.07B
Revenue:
28.32B
Total Assets:
48.81B
Total Cash:
3.82B


News about "Eli Lilly and Company"

eli-lilly-to-supply-additional-doses-of-covid-antibody-drug-to-us-image

Eli Lilly to supply additional doses of COVID antibody drug to U.S.

Source from : Reuters on MSN.com - 2 days ago

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar ...See details»


eli-lilly-and-nyselly-upgraded-by-stocknewscom-to-strong-buy-image

Eli Lilly and (NYSE:LLY) Upgraded by StockNews.com to โ€œStrong-Buyโ€

Source from : Defense World - 13 hours ago

Eli Lilly and (NYSE:LLY โ€“ Get Rating) was upgraded by investment analysts at StockNews.com from a โ€œbuyโ€ rating to a โ€œstrong-buyโ€ rating in a report released on Friday. A number of other research ...See details»


lilly-will-supply-an-additional-150000-doses-of-bebtelovimab-to-us-government-in-ongoing-effort-to-provide-covid-19-treatment-options-image

Lilly will supply an additional 150,000 doses of bebtelovimab to U.S. government in ongoing effort to provide COVID-19 treatment options

Source from : YAHOO!Finance - 2 days ago

Eli Lilly and Company (NYSE: LLY) today announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately $275 million. The ...See details»


lilly-to-supply-additional-150k-doses-of-covid-19-antibody-therapy-to-us-image

Lilly to supply additional 150K doses of COVID-19 antibody therapy to U.S.

Source from : Seeking Alpha - 2 days ago

Eli Lilly (NYSE:LLY) announced a modified purchase agreement with the U.S. government on Wednesday to deliver an extra 150,000 doses of its COVID-19 antibody therapy, bebtelovimab for approximately ...See details»


lilly-declares-third-quarter-2022-dividend-image

Lilly Declares Third-Quarter 2022 Dividend

Source from : Yahoo - 4 days ago

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2022 of $0.98 per share on outstanding common stock.See details»


eli-lilly-and-company-nyselly-shares-acquired-by-yhb-investment-advisors-inc-image

Eli Lilly and Company (NYSE:LLY) Shares Acquired by YHB Investment Advisors Inc.

Source from : ETF Daily News - 5 days ago

YHB Investment Advisors Inc. grew its stake in Eli Lilly and Company (NYSE:LLY โ€“ Get Rating) by 5.7% in the 1st quarter, according to the company in its most recent filing with the Securities & ...See details»


eli-lilly-and-company-nyselly-major-shareholder-lilly-endowment-inc-sells-41857-shares-image

Eli Lilly and Company (NYSE:LLY) Major Shareholder Lilly Endowment Inc Sells 41,857 Shares

Source from : Defense World - 2 days ago

Eli Lilly and Company (NYSE:LLY โ€“ Get Rating) major shareholder Lilly Endowment Inc sold 41,857 shares of the firmโ€™s stock in a transaction on Monday, June 27th. The shares were sold at an average ...See details»


Eli Lilly and Company (NYSE: LLY): Making Its Way Up The Stock Market

Source from : stocksregister - 7 days ago

Eli Lilly and Company (NYSE:LLY) shares, rose in value on Friday, June 24, with the stock price up by 3.92% to the previous dayโ€™s close as strong demand from buyers drove the stock to $324.97.See details»


eli-lilly-to-supply-us-government-with-150000-additional-doses-of-bebtelovimab-image

Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab

Source from : PMLiVE - 1 days ago

The antibody drug treatment has thus far only been authorised for emergency use by the FDA to treat COVID-19 in specific emergency cases in non-hospital settings ...See details»


eli-lilly-and-company-nyselly-shares-acquired-by-nuwave-investment-management-llc-image

Eli Lilly and Company (NYSE:LLY) Shares Acquired by NuWave Investment Management LLC

Source from : ETF Daily News - 7 days ago

Eli Lilly and (NYSE:LLY โ€“ Get Rating) last released its quarterly earnings data on Thursday, April 28th. The company reported $2.62 earnings per share for the quarter, beating the consensus estimate ...See details»


top-analyst-reports-for-meta-platforms-eli-lilly-home-depot-image

Top Analyst Reports for Meta Platforms, Eli Lilly & Home Depot

Source from : YAHOO!Finance - 1 days ago

Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eli Lilly and Company (LLY), and The Home Depot, Inc. (HD).See details»


Is Eli Lilly and Company (NYSE: LLY) A Good Stock To Invest In Right Now?

Source from : stocksregister - 13 days ago

Eli Lilly and Company (NYSE:LLY) price on Friday, June 17, rose 2.94% above its previous dayโ€™s close as an upside momentum from buyers pushed the stockโ€™s value to $296.53. A look at the stockโ€™s price ...See details»


Eli Lilly Gets $275 Million U.S. Pact for Covid-19 Antibody Drug >LLY

Source from : MarketWatch - 2 days ago

By Colin Kellaher Eli Lilly & Co. on Wednesday said it agreed to supply an additional 150,000 doses of its Covid-19 antibody drug bebtelovimab to ...See details»


eli-lilly-unstoppable-share-price-progress-cant-last-forever-image

Eli Lilly: Unstoppable Share Price Progress Can't Last Forever

Source from : Seeking Alpha - 7 days ago

Lilly's share price is +39% over a 12m period, and +293% across the past 5 years. Read more about LLY stock here.See details»